Q1 2026 Holdings
Filed 2026-05-14 | 14 holdings | $915.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx, Inc.(ACLX) | Common Stock | 03940C100 | $269.4M | 2,346,630 | 29.4% |
| Veradermics, Inc.(MANE) | Common Stock | 922967104 | $151.7M | 2,401,868 | 16.6% |
| Zenas BioPharma, Inc(ZBIO) | Common Stock | 98937L105 | $98.5M | 5,037,854 | 10.8% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $97.0M | 2,038,763 | 10.6% |
| Design Therapeutics, Inc.(DSGN) | Common Stock | 25056L103 | $69.4M | 6,526,476 | 7.6% |
| Oric Pharmaceuticals, Inc.(ORIC) | Common Stock | 68622P109 | $58.5M | 4,514,929 | 6.4% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $43.2M | 1,959,896 | 4.7% |
| Mineralys Therapeutics Inc.(MLYS) | Common Stock | 603170101 | $42.4M | 1,563,966 | 4.6% |
| ARS Pharmaceuticals, Inc.(SPRY) | Common Stock | 82835W108 | $32.2M | 4,012,903 | 3.5% |
| Oruka Therapeutics, Inc(ORKA) | Common Stock | 687604108 | $21.1M | 430,330 | 2.3% |
| Oculis Holding AG(OCS) | Ordinary Shares | H5870P102 | $17.0M | 641,022 | 1.9% |
| Nkarta, Inc.(NKTX) | Common Stock | 65487U108 | $7.0M | 3,333,333 | 0.8% |
| enGene Holdings Inc.(ENGN) | Common Shares | 29286M105 | $5.1M | 747,750 | 0.6% |
| Ultragenyx Pharmaceutical Inc.(RARE) | Common Stock | 90400D108 | $2.9M | 137,753 | 0.3% |